Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.44 |
| ▸ | LIPE | Q05469 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.37 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.37 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29595177 | 1.00 | MAPT (0.44) | MAPTENPP2LIPECYP1A2CYP2A6 | |
| SCHEMBL29875461 | 0.88 | MAPT (0.50) | MAPTENPP2LIPECYP1A2ORAI1 | |
| SCHEMBL1427222 | 0.88 | MAPT (0.50) | MAPTENPP2LIPECYP1A2ORAI1 | |
| SCHEMBL15369531 | 0.87 | CYP1A2 (0.62) | MAPTENPP2CYP1A2CYP2A6CA7 | |
| SCHEMBL29954360 | 0.87 | IDO1 (0.48) | MAPTCYP1A2CA6 | |
| SCHEMBL12807507 | 0.87 | MAPT (0.38) | MAPTENPP2LIPECYP1A2CYP2A6 | |
| SCHEMBL29950871 | 0.87 | CYP1A2 (0.62) | MAPTENPP2CYP1A2CYP2A6CA7 | |
| SCHEMBL31621070 | 0.85 | ENPP2 (0.40) | MAPTENPP2LIPE | |
| SCHEMBL3421359 | 0.85 | CYP1A2 (0.41) | MAPTENPP2LIPECYP1A2ORAI1 | |
| SCHEMBL17728135 | 0.85 | MAPT (0.36) | MAPTENPP2LIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023206427-A1 | SECONDARY BATTERY, BATTERY MODULE COMPRISING SAME, BATTERY PACK, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2023-11-02 | — | — | WO | disclosed |
| WO-2023206360-A1 | SECONDARY BATTERY AND BATTERY MODULE COMPRISING SAME, BATTERY PACK, AND ELECTRICAL DEVICE | 宁德时代新能源科技股份有限公司 | 2023-11-02 | — | — | WO | disclosed |
| CN-115819466-A | Binuclear iridium complex and application thereof in organic electronic device | 广州追光科技有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-111094295-B | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2022-05-17 | — | — | CN | disclosed |
| CN-111094295-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2020-05-01 | — | — | CN | disclosed |
| EP-1957606-B1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINIESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-11-08 | — | — | EP | disclosed |
| US-9017825-B2 | Anthracene derivatives and their use in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-04-28 | — | — | US | disclosed |
| US-9017825-B2 | Anthracene derivatives and their use in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-04-28 | — | — | US | disclosed |
| US-8173273-B2 | Anthracene derivatives, method for preparation thereof, and organic electronic device using the same | LG CHEM, LTD. (KR) | 2012-05-08 | — | — | US | disclosed |
| US-8021766-B2 | layer containing an organic compound sandwiched between the pair of electrodes; high color purity, high efficiency, high luminance, and a long life; nonaggregate; cost efficiency | CANON KABUSHIKI KAISHA (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20100044681-A1 | Novel Anthracene Derivatives, Method for Preparation Thereof, and Organic Electronic Device Using the Same | LG CHEM, LTD. (KR) | 2010-02-25 | — | — | US | disclosed |
| US-20080303423-A1 | Novel Materials For Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-12-11 | — | — | US | disclosed |
| US-20080303423-A1 | Novel Materials For Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-12-11 | — | — | US | disclosed |
| WO-2007123339-A9 | NOVEL ANTHRACENE DERIVATIVES, METHOD FOR PREPARATION THEREOF, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEMICAL LTD (KR) | 2008-12-11 | — | — | WO | disclosed |
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
| WO-2007123339-A1 | NOVEL ANTHRACENE DERIVATIVES, METHOD FOR PREPARATION THEREOF, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2007-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | GTF2I, FLI1, GLB1 | MAPT 2285/4885ENPP2 4252/4885LIPE 241/4885 |
| US-20100044681-A1 | Novel Anthracene Derivatives, Method for Preparation Thereof, and Organic Electronic Device Using the Same | XPOT, TOMM22, TIMM10 | MAPT 2318/4885ENPP2 300/4885LIPE 3249/4885 |
| US-20080303423-A1 | Novel Materials For Organic Electroluminescent Devices | ANXA2, ANXA7, ANXA1 | MAPT 2454/4885ENPP2 926/4885LIPE 4276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.